Search research articles
Contact Us
Filters
Showing results (61-70 of 102) with videos related to
Page
of 11
Sort By:
Pediatric Blood & Cancer
|
November 6, 2024
Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531
Julie Voeller, Howard M Katzenstein, Arlene Naranjo, et al.
Oncotarget
|
June 9, 2015
Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism
Stefano J Mandriota, Linda J Valentijn, Laurence Lesne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2021
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group
Meredith S Irwin, Arlene Naranjo, Fan F Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
Reprogramming neuroblastoma by diet-enhanced polyamine depletion
Sarah Cherkaoui, Lifeng Yang, Matthew McBride, et al.
British Journal of Cancer
|
January 10, 2024
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial
Michael D Hogarty, David S Ziegler, Andrea Franson, et al.
Journal of Clinical Microbiology
|
May 23, 2008
Isolation and characterization of a novel Francisella sp. from human cerebrospinal fluid and blood
Kiersten J Kugeler, Paul S Mead, Karin L McGowan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2016
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression
Nicholas F Evageliou, Michelle Haber, Annette Vu, et al.
JAMA
|
August 28, 2019
Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial
Julie R Park, Susan G Kreissman, Wendy B London, et al.
The EMBO Journal
|
February 25, 2022
Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance
Jorida Çoku, David M Booth, Jan Skoda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2006
Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma
Christina M Coughlin, Mark D Fleming, Richard G Carroll, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 102) with videos related to
Sort By:
Page
of 11
Pediatric Blood & Cancer
|
November 6, 2024
Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531
Julie Voeller, Howard M Katzenstein, Arlene Naranjo, et al.
Oncotarget
|
June 9, 2015
Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism
Stefano J Mandriota, Linda J Valentijn, Laurence Lesne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2021
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group
Meredith S Irwin, Arlene Naranjo, Fan F Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
Reprogramming neuroblastoma by diet-enhanced polyamine depletion
Sarah Cherkaoui, Lifeng Yang, Matthew McBride, et al.
British Journal of Cancer
|
January 10, 2024
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial
Michael D Hogarty, David S Ziegler, Andrea Franson, et al.
Journal of Clinical Microbiology
|
May 23, 2008
Isolation and characterization of a novel Francisella sp. from human cerebrospinal fluid and blood
Kiersten J Kugeler, Paul S Mead, Karin L McGowan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2016
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression
Nicholas F Evageliou, Michelle Haber, Annette Vu, et al.
JAMA
|
August 28, 2019
Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial
Julie R Park, Susan G Kreissman, Wendy B London, et al.
The EMBO Journal
|
February 25, 2022
Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance
Jorida Çoku, David M Booth, Jan Skoda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2006
Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma
Christina M Coughlin, Mark D Fleming, Richard G Carroll, et al.
Page
of 11